Healthcare · AI · Early-stage investing
Backing early-stage healthcare and AI founders — building products that can survive real clinical environments, not just demos.
Fast decisions. High conviction. Clear passes.
Background
Raj Popuri is a healthcare technology operator turned investor. He founded iProcedures — a clinical workflow platform for perioperative care — and scaled it to a $1.43B exit through Provation Medical and Fortive.
RASS Ventures was built from that experience. Two decades of understanding how healthcare systems actually buy, deploy, and extract value from technology. This is not theoretical investing. The perspective comes from building, selling, integrating, and exiting in complex clinical environments.
Most investors evaluate healthcare from the outside. This perspective comes from having built inside it. That's the lens every investment is evaluated through.
Founded Arrowhead Technologies. Acquired by Starlight Ventures — first exit.
Founded iProcedures — perioperative data management and anesthesia workflow platform for acute care.
iProcedures acquired by Provation Medical (Clearlake Capital). Merged and positioned for strategic exit.
Provation sold to Fortive for $1.43B. One of healthcare IT's landmark exits of the decade.
Active early-stage investor through RASS Ventures — direct checks and co-investments across healthcare AI, clinical SaaS, and AI-driven B2B platforms with complex workflows. Investments at pre-seed and seed, $250K–$1M initial checks.
Investment thesis
Healthcare AI · Clinical workflow software · AI-driven B2B platforms in complex, regulated environments
Healthcare-first. Selectively invests in AI platforms where the disruption is clear and the path to real-world enterprise adoption — including healthcare — is evident.
01
AI applied to real clinical workflows — decision support, documentation, and diagnostics that integrate into existing systems without breaking existing care delivery.
02
Patient engagement and chronic disease platforms aligned to how healthcare is delivered and paid for — measurable outcomes, sustainable unit economics.
03
Enterprise software for health systems and providers where workflow depth creates genuine defensibility — the kind that becomes infrastructure, not a feature.
The difference
Most early investors offer capital and introductions. RASS brings operating judgment from building and exiting in healthcare — not reviewing decks.
The judgment is earned, not borrowed.
We don't invest in many companies. We pass quickly when the founder, valuation, or differentiation doesn't hold up.
Technical and clinical evaluation before financial modeling. EHR integrations, clinical workflow constraints, regulatory pathways — understood from direct experience, not frameworks.
Healthcare enterprise sales is a different game. Direct relationships with health system leaders, GPO networks, and clinical decision-makers — and the credibility of a proven exit in the sector.
Having sold twice to strategic acquirers, RASS knows what buyers want. Product architecture, integration story, customer concentration, contract structures — shaped early, not scrambled at exit.
Active across direct investments and partner funds — Florida Funders, Pack Ventures, Sugati Ventures, and Arcventis Health Partners — with institutional co-investment available when it matters.
Investments are made directly through RASS Ventures and alongside a small set of partner funds. Initial checks are typically $250K–$1M at pre-seed and seed. Founders work directly with Raj — not through a layered fund structure.
Get in touch
RASS invests in a small number of companies each year. Primary focus is healthcare — founders who understand clinical workflows, enterprise buying dynamics, and real-world adoption. Selectively invests in AI-driven B2B platforms with complex workflows where the path to real-world enterprise adoption — including healthcare — is clear.
If you're still figuring out the problem, this is probably not the right fit.
If you know what you're building, who it's for, and why your team is the one to build it — I'd be happy to take a look.
Include a brief note on what you're building, your stage and traction, and a link to your deck.